Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Aspect Biosystems

Aspect Biosystems
2013 FOUNDED
PRIVATE STATUS
31-40 EMPLOYEES
Series A LATEST DEAL TYPE
$20M LATEST DEAL AMOUNT
14 INVESTORS
Description

Operator of a biotechnology company designed to innovate at the intersection of biology, medicine, and engineering to build living human tissues. The company's proprietary microfluidic 3D bioprinting technology is creating advances in understanding fundamental biology, disease research, development of novel therapeutics and regenerative medicine, enabling the creation of living, human tissues for medical research, therapeutic discovery, and regenerative medicine products.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Primary Office
  • 1781 West 75th Avenue
  • Vancouver, British Columbia V6P 6P2
  • Canada

+1 (604) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Aspect Biosystems’s full profile, request a free trial.

Aspect Biosystems Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC (Series A) 09-Jan-2020 $20M 000.00 Completed Generating Revenue
7. Grant 15-Nov-2018 00.00 00000 Completed Generating Revenue
6. Early Stage VC 15-Mar-2018 00000 00000 Completed Generating Revenue
5. Early Stage VC 31-Jul-2017 Completed Generating Revenue
4. Seed Round 01-Oct-2016 Completed Generating Revenue
3. Seed Round 30-Jun-2015 Completed Startup
2. Grant 01-Sep-2014 $50.3K Completed Startup
1. Accelerator/Incubator 01-Nov-2013 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Aspect Biosystems Competitors (9)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Organovo Pending Transaction (M&A) San Diego, CA 00 0000 000000&0 0000
0000000 Venture Capital-Backed Villaz-Saint-Pierre, Switzerland 0000
00000000 Formerly VC-backed Schlieren, Switzerland 00 000.00 0000000000 0 000.00
000000 0000000000 Venture Capital-Backed Austin, TX 0 00.000 0000000000 0 00.000
0000000000 Venture Capital-Backed Westminster, CO 00 00000 000000000 00 00000
To view this company’s complete list of competitors, request access »

Aspect Biosystems Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Radical Ventures Venture Capital Minority 000 0000 000000 0
Rhino Ventures Venture Capital Minority 000 0000 000000 0
Western Economic Diversification Canada Government 000 0000 000000 0
Genome British Columbia Not-For-Profit Venture Capital Minority 000 0000 000000 0
Civilization Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 14 investors. Get the full list »

Aspect Biosystems Executive Team (6)

Name Title Board
Seat
Contact
Info
Tamer Mohamed Co-Founder, Chief Executive Officer, President & Board Member
Michael Liggett Chief Financial Officer
Sandra Keyton Chief Human Resources Officer
Samuel Wadsworth Ph.D Co-Founder & Chief Scientific Officer
Simon Beyer Ph.D Co-Founder & Chief Product Officer
You’re viewing 5 of 6 executives. Get the full list »

Aspect Biosystems Board Members (5)

Name Representing Role Since Contact
Info
Andrew Haughian Pangaea Ventures Board Member 000 0000
Christopher Bissonnette Ph.D Pallasite Ventures Board Member 000 0000
James Hatton Aspect Biosystems Board Member 000 0000
Konrad Walus Ph.D Aspect Biosystems Co-Founder & Board Member 000 0000
Tamer Mohamed Aspect Biosystems Co-Founder, Chief Executive Officer, President & Board Member 000 0000